E3 ubiquitin ligases as novel targets for inflammatory diseases.

Pharmacol Res

Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address:

Published: April 2016

Ubiquitination is one of the post translational modifications which decide the fate of various proteins in the cells, by either directing them towards proteasomal degradation or participation in several cell signalling pathways. Recently, the role of ubiquitination has been unravelled in pathogenesis and progression of various diseases, where inflammation is critical, like obesity, insulin resistance, atherosclerosis, angiotensin-II induced cardiac inflammation and asthma. E3 ligases are known to be instrumental in regulation of the inflammatory cascade. This review focuses on the role of different E3 ligases in the development of inflammatory diseases and thus may help us to target these E3 ligases in future drug discovery to prevent inflammation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.02.006DOI Listing

Publication Analysis

Top Keywords

inflammatory diseases
8
ubiquitin ligases
4
ligases novel
4
novel targets
4
targets inflammatory
4
diseases ubiquitination
4
ubiquitination post
4
post translational
4
translational modifications
4
modifications decide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!